// App-Quantinova.ai

: Hematopoietic Stem Cell Transplantation in Children with Refractory Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Yasuhiro Okamoto

Principal Investigators

  • Yozo Nakazawa

  • Masami Inoue

  • Kenichiro Watanabe

  • Hiroaki Goto

  • Nao Yoshida

  • Maiko Noguchi

  • Atsushi Kikuta

  • Koji Kato

  • Yoshiko Hashii

  • Yoshiko Atsuta

  • Motohiro Kato

Medical Centers

  • Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

  • Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan

  • Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan

  • Department of Hematology and Oncology, Shizuoka Childrens Hospital, Shizuoka, Japan

  • Division of Hemato-Oncology/Regenerative Medicine, Kanagawa Childrens Medical Center, Yokohama,

  • Department of Hematology and Oncology, Childrens Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya,

  • Department of Clinical Research, National Kyushu Cancer Center, Fukuoka, Japan

  • Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Japanese Data Center for Hematopoietic Cell Transplantation,

  • Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Melphalan

  • Busulfan

  • Thiotepa

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A